Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.gov public full text Public Domain

A Phase 1 Study of PV-001 9-valent Human Papillomavirus(HPV) Vaccine

POSVAX · 2022
ClinicalTrials.gov · Datasets · License: Public Domain · 2022
Open Source ↗
hpv-infections
Study Title: Evaluation of the Safety and Immunogenicity of a Third Dose of PV-001 in Healthy Women Aged 19-45 Objective: To assess the safety and antibody response of a third dose of PV-001 in healthy adult female participants. Key Questions Is PV-001 safe? What adverse events may occur after vaccination? Does PV-001 produce an effective immune response? Participant Activities : Three clinic visits for screening and vaccination Blood samples collected on a set schedule Monitoring for side effects after vaccination
Conceptio Open Archive

Analyze & explore related research in Conceptio

Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.

This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 903346
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive